Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 794 | 69 | 0.4467 | 0.5287 | 0.0869 | 0.0889 |
WM-115 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 2364 | 364 | 0.5201 | 0.5099 | 0.1540 | 0.1408 |
A-375 | Vemurafenib | I-BET | 0.100 | 0.000 | uM | 72 | hr | 3 | 7332 | 213 | 0.5221 | 0.5189 | 0.0291 | 0.0308 |
MMAC-SF | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 633 | 84 | 0.3383 | 0.4387 | 0.1327 | 0.1238 |
WM-115 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2523 | 353 | 0.5643 | 0.5494 | 0.1399 | 0.1416 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1744 | 239 | 0.0788 | 0.0842 | 0.1370 | 0.1524 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 1046 | 176 | 0.5360 | 0.5003 | 0.1683 | 0.1840 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 2084 | 267 | 0.4725 | 0.4743 | 0.1281 | 0.1338 |
A-375 | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 1557 | 332 | 0.0587 | 0.0613 | 0.2132 | 0.2108 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 965 | 257 | 0.4362 | 0.4219 | 0.2663 | 0.2479 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1953 | 173 | 0.4629 | 0.4954 | 0.0886 | 0.0888 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 3 | 3934 | 188 | 0.2747 | 0.3080 | 0.0478 | 0.0484 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 612 | 155 | 0.2816 | 0.3619 | 0.2533 | 0.2613 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 2867 | 273 | 0.6745 | 0.6528 | 0.0952 | 0.0956 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 2950 | 229 | 0.1424 | 0.1538 | 0.0776 | 0.0753 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 3.160 | uM | 72 | hr | 3 | 562 | 189 | 0.2298 | 0.2686 | 0.3363 | 0.3262 |
WM-115 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2855 | 245 | 0.6787 | 0.7069 | 0.0858 | 0.0799 |
WM-115 | Vemurafenib | I-BET151 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1908 | 303 | 0.4600 | 0.4718 | 0.1588 | 0.1680 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 881 | 262 | 0.3814 | 0.3551 | 0.2974 | 0.3208 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2278 | 211 | 0.5375 | 0.5553 | 0.0926 | 0.0985 |
A-375 | Vemurafenib | I-BET | 0.316 | 0.000 | uM | 72 | hr | 3 | 3925 | 119 | 0.2791 | 0.2900 | 0.0303 | 0.0255 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 750 | 271 | 0.2951 | 0.2855 | 0.3613 | 0.3352 |
WM-115 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 2787 | 194 | 0.6743 | 0.6617 | 0.0696 | 0.0684 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 1115 | 111 | 0.0526 | 0.0571 | 0.0996 | 0.0996 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 625 | 262 | 0.2237 | 0.2820 | 0.4192 | 0.3755 |